TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$125 Million

Kythera Biopharmaceuticals

Follow-on Offering

Co-Manager, March 2015

Provider of a platform which focuses on science and innovation in aesthetic medicine. The company uses the tools of biotechnology to develop prescription therapeutics.